(Bloomberg) -- Grifols SA’s board postponed its capital markets day as Brookfield Asset Management carries out due diligence on a potential takeover offer.Most Read from BloombergHow Air Conditioning Took Over the American OfficeA Guide to Urban Swimming in Europe, Beyond the SeineThe event had been scheduled for Oct. 10, but will now be moved back as the Spanish pharma company’s founding family and Brookfield go ahead with talks on a potential bid, according to a letter Grifols sent to investor
(Bloomberg) -- Brookfield Asset Management is in talks with several investment funds to join its bid to acquire Spanish blood-plasma company Grifols SA, according to people familiar with the matter.Most Read from BloombergDense Cities With Low Emissions Suffer Most From Air Pollution, Study FindsTurkey Plans Istanbul Taxi Surge to Tackle ComplaintsIntergenerational Housing Could Help Older Adults Combat LonelinessAs Rural Hospitals Shutter Maternity Wards, Urban Ones FollowA Loud Warning From th
A Bloomberg article suggests that Brookfield Asset Management is in discussions with banks to raise nearly $11 billion to fund the takeover of Spain-based Grifols (GRFS).